Literature DB >> 8153379

Cardiac lesions after mediastinal irradiation for Hodgkin's disease.

C Glanzmann1, P Huguenin, U M Lütolf, R Maire, R Jenni, V Gumppenberg.   

Abstract

We analysed the risk of myocardial infarctions in 339 patients with Hodgkin's disease treated with radiotherapy (rt) with or without chemotherapy. A total of 112 patients underwent cardiac testing with echocardiography, rest and exercise electrocardiogram and myocardial scintigraphy. Nearly all patients have been treated with < 2.0 Gy per fraction to the anterior cardiac region. A significantly increased risk of myocardial infarctions or of sudden death has been observed (10 patients). No cardia events have been observed in 215 non-smokers without hypertension and without coronary artery disease (CAD) already present before rt. In the heart study group (112 patients), there were 6 patients with probable or proven CAD. Five of these 6 patients had known risk factors for CAD. Echocardiography showed sclerosis of the aortic and or the mitral valves in 34 patients. Of these patients, 2 had a slight and 1 a moderate aortic stenosis, 5 had a slight and 1 a moderate mitral regurgitation. Evidence for a disturbance of the diastolic function has not been observed. No patient had a clinically relevant pericardial lesion. In patients without risk factors for CAD, there is only a low risk of ischaemic cardiac events after modern mediastinal rt for Hodgkin's disease. Patients should eliminate the known risk factors. There is a high incidence of sclerosis of the mitral and or the aortic valves developing into clinically important lesions in few patients. Decision on the treatment strategy and the rt technique should also involve consideration of the cardiac risk. For routine follow-up, we recommend inclusion of an echocardiography in intervals between 3 and 4 years.

Entities:  

Mesh:

Year:  1994        PMID: 8153379     DOI: 10.1016/0167-8140(94)90008-6

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  13 in total

Review 1.  State-of-the-art issues in Hodgkin's lymphoma survivorship.

Authors:  Shrujal S Baxi; Matthew J Matasar
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

2.  Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study.

Authors:  M B Lund; H Ihlen; B M Voss; A F Abrahamsen; O Nome; J Kongerud; M Stugaard; K Forfang
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 3.  Late complications after treatment for Hodgkin lymphoma.

Authors:  Andrea K Ng
Journal:  Curr Hematol Malig Rep       Date:  2008-07       Impact factor: 3.952

Review 4.  Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.

Authors:  Danielle Harake; Vivian I Franco; Jacqueline M Henkel; Tracie L Miller; Steven E Lipshultz
Journal:  Future Cardiol       Date:  2012-07

5.  The prevention of cardiovascular disease in cancer survivors.

Authors:  Iyad N Daher; Tina R Daigle; Nirmanmoh Bhatia; Jean-Bernard Durand
Journal:  Tex Heart Inst J       Date:  2012

6.  Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

Authors:  Aileen B Chen; Rinaa S Punglia; Karen M Kuntz; Peter M Mauch; Andrea K Ng
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

Review 7.  [Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?].

Authors:  Frank Lohr; Felix Heggemann; Theano Papavassiliu; Mostafa El-Haddad; Oliver Tomé; Dietmar Dinter; Barbara Dobler; Uta Kraus-Tiefenbacher; Martin Borggrefe; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

8.  3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.

Authors:  Dirk Vordermark; Ines Seufert; Franz Schwab; Oliver Kölbl; Margret Kung; Christiane Angermann; Michael Flentje
Journal:  Radiat Oncol       Date:  2006-04-20       Impact factor: 3.481

Review 9.  Cardiotoxicity of mediastinal radiotherapy.

Authors:  Ivica Ratosa; Maja Ivanetic Pantar
Journal:  Rep Pract Oncol Radiother       Date:  2019-10-30

10.  Cardiac damage after treatment of childhood cancer: a long-term follow-up.

Authors:  Veronika Velensek; Uros Mazic; Ciril Krzisnik; Damjan Demsar; Janez Jazbec; Berta Jereb
Journal:  BMC Cancer       Date:  2008-05-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.